Cytel, NERI, Pharsight
Wednesday News Bulletins
Briefs for Wednesday, July 18.
A commercial North Carolina institutional review board (IRB), Copernicus Group IRB, has received ISO 9001 certification. The company has a paperless system to manage clinical trial forms. “To our knowledge, CGIRB is the only central IRB that has achieved this certification. It is further evidence to our clients and the subjects of research studies that the quality of our services and our strong business practices are unsurpassed,” said Bruce Tomason, CEO. Here's a release. There's a split between early- and late-phase contract research organizations (CROs), according to this wire service article. Some small sponsors and biotechnology firms are delaying the launch of projects, analysts say, favoring late-phase specialists. Health Decisions, a technology-oriented contract research organization, appointed a new chief technology officer, Bryan Minihan. He'll be working on the company's system that, among other features, supports adaptive clinical trials. Minihan previously worked at GSK, Accenture, Intuit, and Cisco. “I’m excited to be…more...
For the all the excitement and anticipation around adaptive designs for clinical trials, there’s always been one pesky fly in the ointment. Do regulators actually bless adaptive approaches when sponsors propose…more...
As we noted in an article yesterday, the annual Regulatory Affairs Professionals Society (RAPS) meeting, held last month in Boston, had a fascinating session on adaptive designs from a regulatory perspective.…more...
Adaptive trials are very much on the minds of the clinical trial community, with a few big sponsors like Novartis and Merck plunging into the systems necessary to support them. Many…more...
United BioSource (UBC) has been built one acquisition at a time from a 9-figure investment war chest. The company provides clinical trial research services, but is not a contract research organization (CRO) in any traditional sense. It counts some CROs as customers and calls itself a specialty services organization. With 1,000 employees, UBC reports that more than…more...
Clinical data standards seem wonderful in the abstract. On a white board, the work of CDISC and HL7 should make life easier, cheaper and faster for everyone involved in any clinical trial, just as broccoli should be good for anybody’s health. Thinking about buying broccoli is more common than buying it. That’s surprising, given the FDA’s encouragement…more...
The math of adaptive trials is hairy. But the appeal is simple. Adaptive trials can reveal the optimal dose in a single trial—not six. They can identify dud drugs early. The approach can require significantly smaller sample sizes and save big companies billions of dollars. There’s just one mathematical fly in the clinical ointment. Adaptive trials will,…more...
In the world of running, the ultramarathon is anything longer than a 26-mile course. Some people run from one rim of the Grand Canyon, down to the bottom, and up to the other rim. And back. In a day. They call that an “R2R2R.” Adaptive designs are the ultramarathons of clinical trials. Adaptive designs will test even…more...
Briefs for Wednesday, July 18.
News Friday, June 29.
The leading biostatistical house and a top EDC vendor say they have a better way to move clinical data toward analysis.
An expanding ClinPhone, with a headquarters in the UK and major offices in the U.S., talks about a new product and its overall strategy.
Briefs for Tuesday, June 5.
Despite a cautious attitude for pricing EDC, Phoenix Data Systems is thriving. A recent announcement from the company noted customers signing up for four pivotal Phase III trials.
News bulletins for Friday, April 27.
Organizations
Conferences
Info & Opinion
© 2010 ClinPage. All Rights Reserved.